Testing week is an initiative that was launched by HIV in Europe in 2013 to help more people to become aware of their HIV status. In 2015 testing week expanded to include hepatitis and was named European HIV-Hepatitis Testing Week. The testing week takes place during the last week of November.
Why is a European Testing Week needed?
Today, at least one in three of the 2.5 million people living with HIV in Europe are unaware that they are HIV positive. Half of those living with HIV are diagnosed late – which delays access to treatment. Hepatitis B and C are common among people at risk of and living with HIV. Around 13.3 million people are living with hepatitis B in the WHO European Region; approximately 15–40% of infected individuals will develop cirrhosis, liver failure or hepatocellular carcinoma. 15 million people in the WHO European Region are living with hepatitis C; however, the majority of people with hepatitis C remain undiagnosed and only a small minority in Europe (3.5%) receive treatment.
These statistics suggest that we need to be doing more to encourage individuals who are unknowingly living with HIV and/or hepatitis to take a test, and to better target people who could be at risk.
If you have any questions or would like more information, please go to the Testing Week website or contact the HIV in Europe secretariat: email@example.com.
2013 Evaluation Report
2014 Evaluation Report
2015 Evaluation slides
2015 Evaluation one-pager